Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.65M 19.1M 17.52M 33.17M 2.28B 33.74M 228M 89.47M 1.11B 88.72M 86.77M 3.84B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.87M 34.1M 31.29M 59.22M 4.06B 60.25M 407M 160M 1.99B 158M 155M 6.85B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day-2.78%
1 week-2.78%
Current month-14.63%
1 month-32.69%
3 months-16.67%
6 months-14.63%
Current year+6.06%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.83
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-2.78%-46.97%+133.33% 1.33M
+0.60%-16.75%+27.34%+488.82% 2.23B
-3.47%-4.53% - - 1.96B
0.00%-2.13%-39.67%-61.02% 1.68B
-1.02%-19.41%+94.89%+627.15% 1.4B
-0.46%+3.12%-40.77%+40.52% 1.22B
+0.49%+0.24%+311.20%+921.00% 1.1B
-2.40%+0.74%+49.15%+29.43% 939M
-9.94%-23.19%+22.19%+30.82% 706M
-2.22%-4.35%-41.02%-90.30% 438M
Average -2.12%-5.89%+37.37%+235.53% 1.17B
Weighted average by Cap. -1.47%-6.88%+47.82%+302.79%

Financials

2015 2016
Net sales 25.48M 22.27M 20.6M 18.9M 35.77M 2.46B 36.39M 246M 96.5M 1.2B 95.69M 93.59M 4.14B 32.33M 28.26M 26.13M 23.98M 45.39M 3.12B 46.18M 312M 122M 1.52B 121M 119M 5.25B
Net income 5.49M 4.8M 4.44M 4.08M 7.71M 529M 7.85M 52.97M 20.81M 259M 20.63M 20.18M 893M 2.06M 1.8M 1.67M 1.53M 2.89M 199M 2.94M 19.87M 7.81M 96.99M 7.74M 7.57M 335M
Net Debt 24.8M 21.68M 20.05M 18.4M 34.82M 2.39B 35.43M 239M 93.94M 1.17B 93.15M 91.1M 4.03B 18.56M 16.22M 15M 13.77M 26.06M 1.79B 26.51M 179M 70.29M 873M 69.7M 68.17M 3.02B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
346
Date Price Change Volume
13/07/26 $0.003500 -2.78% 46,020
10/07/26 $0.003600 0.00% 14,270
  1. Stock Market
  2. Stocks
  3. AOXG Stock